In Depth 24 Jan 2025 Why are there only 20 cell and gene therapies in Europe? There are 20 cell and gene therapies on Europe’s market versus 43 in the U.S. Find out more about this ecosystem. January 24, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jan 2025 Curing ALS? Sixteen companies developing new treatments in 2025 Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025. January 22, 2025 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Jan 2025 Ten first-in-class drugs on track for FDA approval in 2025 As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025. January 16, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 15 Jan 2025 CRISPR: The gene editing tool changing the world (2025 update) CRISPR-Cas9 has changed the world with the promise of making gene editing much easier and faster than before. But what is its real potential? January 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2025 Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground Explore advances in von Willebrand disease treatment, including Star Therapeutics’ VGA039, and other key players in the space. January 9, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Expert Advice 6 Jan 2025 What to look for in a biotech incubator Building a biotech startup can be a daunting task and often founders rely on incubators – but how to choose the right one? January 6, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 25 Dec 2024 When biotech makes Christmas miracles a reality Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope for the future. December 25, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 18 Dec 2024 AI + CRISPR: The explosive fusion that will redefine biotechnology With AI taking more and more space in biotech, CRISPR stands out as one of the most promising avenues for AI integration. December 18, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 13 Dec 2024 Is China the future of biotech? Delve into the ongoing transformation of China’s biotech industry in the last 10 years and in the future evolving geopolitical context. December 13, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2024 Biotech in 2024: A retrospective 2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism? December 10, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 2 Dec 2024 The rise of cancer vaccines: A new era in immunotherapy Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors. December 2, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Nov 2024 Seven miRNA-focused companies pioneering new therapies in 2024 Delve into the field of miRNA with seven companies with miRNA-focused candidates in the pipeline in 2024, from oncology to neurodegeneration. November 26, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email